While IGF2BP1 is generally characterized as an oncogenic RNA-binding protein that stabilizes m6A-modified transcripts to support tumor growth, its high expression in our cohort was independently associated with reduced levels of pSTAT3 and, notably, with improved overall survival. This evidence concerns the gene IGF2BP1 and neoplasm.